stockportfolio.pro
ACADIA Pharmaceuticals Inc. Gross Profit 2009–2025
ACADIA Pharmaceuticals Inc. (ACAD) annual gross profit by fiscal year, computed from SEC filings. Compound growth +30.3%/yr over 16 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $982.51M | 91.7% | +12.2% |
| FY 2024 | $875.96M | 91.5% | +27.9% |
| FY 2023 | $684.80M | 94.3% | +35.1% |
| FY 2022 | $507.07M | 98.0% | +7.1% |
| FY 2021 | $473.30M | 97.8% | +9.7% |
| FY 2020 | $431.54M | 97.7% | +31.7% |
| FY 2019 | $327.73M | 96.7% | +55.0% |
| FY 2018 | $211.43M | 94.5% | +82.5% |
| FY 2017 | $115.82M | 92.7% | +712.7% |
| FY 2016 | $14.25M | 82.2% | — |
| FY 2015 | — | — | — |
| FY 2014 | — | — | — |
| FY 2013 | — | — | — |
| FY 2012 | — | — | — |
| FY 2011 | — | — | — |
| FY 2010 | — | — | — |
| FY 2009 | — | — | — |
Source: ACADIA Pharmaceuticals Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for ACADIA Pharmaceuticals Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeACADIA Pharmaceuticals Inc. — frequently asked questions
What is ACADIA Pharmaceuticals Inc.'s gross profit?
ACADIA Pharmaceuticals Inc. (ACAD) reported gross profit of $982.51M for fiscal year 2025, per its SEC filings.
How has ACADIA Pharmaceuticals Inc.'s gross profit changed over time?
Between fiscal 2009 and 2025, ACAD's gross profit grew at roughly 30.3% per year (compound annual rate), from $14.25M to $982.51M.
Where does this data come from?
Figures are computed from ACADIA Pharmaceuticals Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.